Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether the appellant was entitled to exemption from service tax as a clinical research organisation under the exemption notification for clinical trials; (ii) whether penalty could survive once the exemption claim was accepted and the other tax liability was otherwise discharged.
Issue (i): Whether the appellant was entitled to exemption from service tax as a clinical research organisation under the exemption notification for clinical trials.
Analysis: The exemption was available to taxable service provided by a clinical research organisation approved to conduct clinical trials by the Drugs Controller General of India in relation to testing and analysis of newly developed drugs on human participants. The record showed that the clinical trials were undertaken under tripartite agreements carrying protocol approvals and that entries had been made in the Clinical Trial Registry of India. The relevant Drugs and Cosmetics Rules, 1945 provisions required permissions for clinical trials and registration, but the expression clinical research organisation was not separately defined in those Rules. On that basis, a general, separate approval of the institution for every trial was not shown to be a statutory prerequisite for the exemption.
Conclusion: The appellant satisfied the conditions of the exemption notification and was not liable to service tax under section 65(105)(zzh) of the Finance Act, 1994 on the clinical trial activity.
Issue (ii): Whether penalty could survive once the exemption claim was accepted and the other tax liability was otherwise discharged.
Analysis: Since the clinical trial receipts were held exempt and the appellant had discharged the tax liability under the other confirmed heads, the foundation for penal action did not survive.
Conclusion: The penalty under section 78 of the Finance Act, 1994 was not sustainable.
Final Conclusion: The demand relating to clinical trials was set aside, the penalty was deleted, and the appeal succeeded in full.
Ratio Decidendi: Exemption for clinical trial services cannot be denied where the trial activity is conducted under approved protocols and registry compliance, unless the notification or governing rules clearly require a separate general approval for each trial.